A PHASE 2b, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN 18 THROUGH
Clinical Trial Grant
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Pfizer, Inc.
Start Date
August 21, 2019
End Date
February 1, 2023
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Pfizer, Inc.
Start Date
August 21, 2019
End Date
February 1, 2023